Introduction: Genomics has the potential to transform medicine by identifying genetic risk factors that predispose people to certain illnesses. Use of genetic screening is rapidly expanding and shifting towards screening all patients regardless of known risk factors, but research is limited on the success of broad population-level outreach for genetic testing and the effectiveness of different outreach methods across diverse populations. In this study, we tested the effectiveness of Digital Only (emailing and texting) and Brochure Plus Digital (mailed brochure, emailing, and texting) outreach to encourage a diverse patient population to participate in a large hospital system’s whole genome sequencing program.Methods: Disproportionate strati...
Public involvement in research occurs when the public, patients, or research participants are active...
© 2018, American College of Medical Genetics and Genomics. Purpose: To evaluate the efficiency of ex...
2007 Background: NCCN now endorses BRCA founder mutation genetic testing (GT) via longitudinal st...
Background: A national priority in the United States is to promote patient engagement in cancer geno...
Recent population-wide genetic testing analyses suggest that over 1% of the general population are c...
The popularity of genetic testing and counselling for hereditary cancer syndromes has increased rapi...
Background: With the advancement in the knowledge of genetics and the emergence of evidence-based re...
Advances in the application of genomic technologies in clinical care have the potential to increase ...
Genetic counselors (GCs) are healthcare professionals who help patients understand howinherited gene...
Introduction: Primary care physicians (PCPs) are considered the gatekeepers of genetic services, but...
Background: Population-based genomic screening has the potential of improving ascertainment of indiv...
Description: Among the two leading causes of death in the United States, each responsible for one in...
BACKGROUND: The COVID-19 pandemic forced healthcare institutions and many clinical research programs...
Objective: To estimate the effect health system engagement on a woman’s awareness of and decision to...
BACKGROUND: Increasingly, genomics is informing clinical practice, but challenges remain for medical...
Public involvement in research occurs when the public, patients, or research participants are active...
© 2018, American College of Medical Genetics and Genomics. Purpose: To evaluate the efficiency of ex...
2007 Background: NCCN now endorses BRCA founder mutation genetic testing (GT) via longitudinal st...
Background: A national priority in the United States is to promote patient engagement in cancer geno...
Recent population-wide genetic testing analyses suggest that over 1% of the general population are c...
The popularity of genetic testing and counselling for hereditary cancer syndromes has increased rapi...
Background: With the advancement in the knowledge of genetics and the emergence of evidence-based re...
Advances in the application of genomic technologies in clinical care have the potential to increase ...
Genetic counselors (GCs) are healthcare professionals who help patients understand howinherited gene...
Introduction: Primary care physicians (PCPs) are considered the gatekeepers of genetic services, but...
Background: Population-based genomic screening has the potential of improving ascertainment of indiv...
Description: Among the two leading causes of death in the United States, each responsible for one in...
BACKGROUND: The COVID-19 pandemic forced healthcare institutions and many clinical research programs...
Objective: To estimate the effect health system engagement on a woman’s awareness of and decision to...
BACKGROUND: Increasingly, genomics is informing clinical practice, but challenges remain for medical...
Public involvement in research occurs when the public, patients, or research participants are active...
© 2018, American College of Medical Genetics and Genomics. Purpose: To evaluate the efficiency of ex...
2007 Background: NCCN now endorses BRCA founder mutation genetic testing (GT) via longitudinal st...